Detalhe da pesquisa
1.
Smallpox still haunts scientists: results of a questionnaire-based inquiry on the views of health care and life science experts and students on preserving the remaining variola virus stocks.
ScientificWorldJournal
; 2013: 672813, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970838
2.
Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach.
J Smooth Muscle Res
; 59: 67-80, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673649
3.
Benefits of Gut Microbiota Reconstitution by Beta 1,3-1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases.
J Alzheimers Dis
; 94(s1): S241-S252, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093695
4.
Beneficial effects of 1,3-1,6 ß-glucans produced by Aureobasidium pullulans on non-esterified fatty acid levels in diabetic KKAy mice and their potential implications in metabolic dysregulation.
J Diabetes Metab Disord
; 22(1): 487-494, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255831
5.
Engraftment and Proliferation of Thermoreversible-Gelation-Polymer-Encapsulated Human Corneal Limbal-Stem-Cells on Ocular Surface of a Cadaver Cornea.
Curr Eye Res
; 48(6): 564-572, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852699
6.
Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study.
IBRO Neurosci Rep
; 15: 90-99, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053632
7.
Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study.
Acta Myol
; 42(4): 129-134, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406382
8.
Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders.
J Alzheimers Dis
; 87(4): 1451-1460, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466942
9.
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study.
BMJ Neurol Open
; 4(1): e000203, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128402
10.
Improvement of sleep and melatonin in children with autism spectrum disorder after ß-1,3/1,6-glucan consumption: An open-label prospective pilot clinical study.
Brain Behav
; 12(9): e2750, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993920
11.
Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study.
Biomed Pharmacother
; 145: 112243, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34840031
12.
ßglucan vaccine adjuvant approach for cancer treatment through immune enhancement (BVACCIEN) in specific immunocompromised populations (Review).
Oncol Rep
; 47(1)2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779494
13.
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease.
BMJ Open Gastroenterol
; 9(1)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167455
14.
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.
Front Immunol
; 13: 870632, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833122
15.
Corrigendum to "Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study" [IBRO Neurosci. Rep. 15 (2023), pp. 90-99].
IBRO Neurosci Rep
; 15: 149-150, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593322
16.
Natural killer cells as a promising tool to tackle cancer-A review of sources, methodologies, and potentials.
Int Rev Immunol
; 36(4): 220-232, 2017 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28471248
17.
Cell-based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report.
Mol Clin Oncol
; 7(3): 493-497, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28894585
18.
Commentary: Beyond "TRIM" Benefits of ß-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19.
Front Immunol
; 12: 620658, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854499
19.
Autologous immune enhancement therapy in a case of gall bladder cancer stage IV after surgical resection and chemotherapy yielding a stable non-progressive disease.
J Cancer Res Ther
; 10(3): 752-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25313776
20.
The known-unknowns in spinal cord injury, with emphasis on cell-based therapies - a review with suggestive arenas for research.
Expert Opin Biol Ther
; 14(5): 617-34, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24660978